Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer.
Dang F, Nie L, Zhou J, Shimizu K, Chu C, Wu Z, Fassl A, Ke S, Wang Y, Zhang J, Zhang T, Tu Z, Inuzuka H, Sicinski P, Bass AJ, Wei W.
Dang F, et al. Among authors: zhou j.
Nat Commun. 2021 Sep 10;12(1):5386. doi: 10.1038/s41467-021-25700-6.
Nat Commun. 2021.
PMID: 34508104
Free PMC article.